ResMed | RMD - Ebit


ResMed reported $499.81M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Ansell USD 146.5M 29.2M Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Cochlear AUD 261.1M 13.9M Dec/2025
CSL USD 2.64B 116M Dec/2025
Fisher & Paykel Healthcare NZD 368.8M 70.6M Jun/2026
Healius AUD 23.7M 26M Dec/2024
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Mayne Pharma AUD -16.2M 13.2M Jun/2024
Nanosonics AUD 9.12M 422K Dec/2025
Polynovo AUD 2.06M 1.18M Dec/2025
Ramsay Health Care AUD 541.1M 20.7M Dec/2025
Regis Healthcare AUD 24.67M 839K Dec/2025
ResMed USD 499.81M 2.22M Mar/2026
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Telix Pharmaceuticals AUD 46.36M 38.32M Jun/2026